Alignment Healthcare holder to sell 500K shares
A trust associated with Alignment Healthcare stock filed to resell 500,000 pre-IPO common shares under Rule 144.
Rhea-AI Filing Summary
Alignment Healthcare, Inc. (ALHC) is the issuer of common stock covered by this notice, which states that JEK TRUST U/A DTD 02/08/2021 plans to sell 500,000 shares of ALHC common stock under Rule 144 through Morgan Stanley Smith Barney LLC. The shares were originally issued pre-IPO in exchange for partnership units.
Positive
- None.
Negative
- None.
Key Figures
Shares proposed to be sold under Rule 144: 500,000 shares
Aggregate market value of proposed sale: $6,515,000.00
Shares sold on August 10, 2026: 298,000 shares
+5 more
8 metrics
Shares proposed to be sold under Rule 144
500,000 shares
Planned sale for JEK TRUST U/A DTD 02/08/2021 through Morgan Stanley Smith Barney LLC
Aggregate market value of proposed sale
$6,515,000.00
Market value stated for 500,000 Alignment Healthcare common shares
Shares sold on August 10, 2026
298,000 shares
Common stock sold for JEK TRUST under a 10b5-1 Sales Plan
Proceeds from August 10, 2026 sale
$4,136,764.62
Sale of 298,000 Alignment Healthcare common shares
Shares sold on July 10, 2026
298,000 shares
Common stock sold for JEK TRUST under a 10b5-1 Sales Plan
Proceeds from July 10, 2026 sale
$5,919,352.80
Sale of 298,000 Alignment Healthcare common shares
Rule 144 filing date of notice
September 10, 2026
Date of notice for the planned Rule 144 sale
Original issuance date of shares
May 9, 2014
Shares issued pre-IPO in exchange for partnership units
Key Terms
Rule 144, 10b5-1 Sales Plan, Shares Issued Pre-IPO, Partnership Units
4 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
10b5-1 Sales Plan regulatory
"10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021"
A 10b5-1 sales plan is a written, prearranged schedule that company insiders use to buy or sell their employer’s stock under a U.S. securities rule, so trades occur automatically at set times or prices regardless of later private information. It matters to investors because it reduces the risk of insider-trading accusations and signals that certain insider trades were planned ahead—like putting transactions on autopilot—while still affecting share supply and market confidence.
Partnership Units financial
"Shares Issued Pre-IPO in exchange for Partnership Units"
Partnership units are ownership shares in a business organized as a partnership; owning a unit is like holding a slice of the company’s profit pie and a claim on its assets. For investors, these units matter because they determine how income, losses and cash distributions are allocated, affect voting or control rights, and often carry different tax and liquidity implications than corporate stock — think of them as a direct stake in the partnership’s performance and payouts.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing disclose for Alignment Healthcare (ALHC)?
The filing discloses that JEK TRUST U/A DTD 02/08/2021 intends to sell 500,000 shares of Alignment Healthcare, Inc. common stock under Rule 144 through Morgan Stanley Smith Barney LLC, using shares that were originally issued pre-IPO in exchange for partnership units.
Who is the broker for the planned Alignment Healthcare (ALHC) Rule 144 sale?
The proposed sale of 500,000 shares of Alignment Healthcare, Inc. common stock under Rule 144 is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.
AI-generated analysis. How Rhea-AI works. Not financial advice.